# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001599298-24-000031
Filing Date
2024-02-20
Accepted
2024-02-20 07:32:56
Documents
113
Period of Report
2023-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | smmt-20231231.htm iXBRL | 10-K | 2241677
2 | EX-10.51 | exhibit1051loanagreement.htm | EX-10.51 | 50891
3 | EX-21.1 | sum-ex211_20231231xxsubsid.htm | EX-21.1 | 5334
4 | EX-23.1 | sum-ex231_20231231xxuscons.htm | EX-23.1 | 2278
5 | EX-31.1 | sum-ex311_20231231xduggan.htm | EX-31.1 | 11276
6 | EX-31.2 | sum-ex312_20231231xzanganeh.htm | EX-31.2 | 11308
7 | EX-31.3 | sum-ex313_20231231xdhingra.htm | EX-31.3 | 11243
8 | EX-32.1 | sum-ex321_20231231xx404906.htm | EX-32.1 | 10520
9 | EX-97.1 | ex971summitclawbackpolicy.htm | EX-97.1 | 17619
15 |  | smmt-20231231_g1.jpg | GRAPHIC | 124799
16 |  | smmt-20231231_g2.jpg | GRAPHIC | 40420
| Complete submission text file | 0001599298-24-000031.txt |  | 10506396

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
10 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | smmt-20231231.xsd | EX-101.SCH | 76791
11 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | smmt-20231231_cal.xml | EX-101.CAL | 93671
12 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | smmt-20231231_def.xml | EX-101.DEF | 357417
13 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | smmt-20231231_lab.xml | EX-101.LAB | 827724
14 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | smmt-20231231_pre.xml | EX-101.PRE | 605423
115 | EXTRACTED XBRL INSTANCE DOCUMENT | smmt-20231231_htm.xml | XML | 1123984

Mailing Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025
Business Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025 650-460-8308
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36866 | Film No.: 24650721
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)